Mark Yarchoan, MD

Associate Professor
Johns Hopkins Hospital, United States

Presentation(s):

• 54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.

  Saturday, March 23, 2024
  8:42am – 8:52am ET